299 results on '"Lee, M.A."'
Search Results
2. Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial
3. 970P Real-world multi-center study of systemic treatment after first-line atezolizumab plus bevacizumab for advanced hepatocellular carcinoma in Asia-Pacific countries
4. Development of Machine Learning Algorithms to Predict Being Lost to Follow-up After Hip Arthroscopy for Femoroacetabular Impingement Syndrome
5. Robust statistics for image deconvolution
6. Faster catalog matching on Graphics Processing Units
7. Clinical impact of tumor volume reduction in rectal cancer following preoperative chemoradiation
8. Renin Gene Expression and Hypertension in Transgenic Animals
9. 116P Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer
10. OD2-2 Trastuzumab plus FOLFOX for gemcitabine/cisplatin refractory HER2-positive biliary tract cancer: A multi-institutional phase II trial of the Korean Cancer Study Group (KCSG-HB19-14)
11. 78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)
12. 56P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)
13. 55P Subsequent anticancer therapy (SAT) analysis from 3-year follow-up of the phase III TOPAZ-1 study of durvalumab plus gemcitabine and cisplatin in biliary tract cancer (BTC)
14. 615MO Phase I/II study of D3S-001, a second generation KRAS G12C inhibitor in advanced/metastatic solid tumors with KRAS G12C mutations
15. 524P A phase II study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with metastatic colorectal cancer who failed two prior standard chemotherapies
16. Solution NMR structure of Vibrio cholerae ferrous iron transport protein C (FeoC)
17. Specular refection at a non-stationary shock: A simple model
18. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer
19. Packaging of closed chamber PCR‐chips for DNA amplification
20. 955P Prognostic factor analysis of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: Korean cancer study group (KCSG) study
21. 952P Prognostic implication of serum alpha-fetoprotein in patients with unresectable hepatocellular carcinoma treated with regorafenib
22. 677P Preliminary findings from a phase I, open-label, dose-finding study of SNB-101 in patients with advanced solid tumors
23. 643P A phase Ib/IIa study to assess the safety, tolerability, pharmacokinetics, and antitumor activity of YYB101, hepatocyte growth factor neutralizing humanized monoclonal antibody, in combination with irinotecan in metastatic or recurrent colorectal cancer patients (NOV110501-201)
24. 104P Final analysis of the prospective, randomized phase II STAMP trial: Adjuvant gemcitabine plus cisplatin (GemCis) versus capecitabine (CAP) in node-positive extrahepatic cholangiocarcinoma (CCA)
25. Welfare myths: The transmission of values and work among TANF families
26. Corrigendum to “78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)”: [Annals of Oncology 33 (2022) S1462-S1463]
27. HPR80 Biosimilars Policy Framework for the Private Sector in the United Arab Emirates
28. Measuring symptom load in Idiopathic Parkinson's disease
29. Preserving the Ninth Circuit.
30. Inflammatory markers, rather than conventional risk factors, are different between carotid and MCA atherosclerosis
31. 101P HIF1-α depletion overcomes resistance to oxaliplatin in colorectal cancer via ERK signalling pathway
32. 105P Prospective, open-label, observational study of cetuximab for metastatic colorectal carcinoma (mCRC): The OPTIM1SE study
33. Main Street/Market Street Historic District
34. Boosters in petticoats: California women and the chamber of commerce, 1880-1930
35. Self-employment disadvantage in the working lives of blacks and females
36. Local labor markets and caseload decline in Louisiana in the 1990s
37. California's El Camino Real and Its HIstoric Bells
38. An expanded cortical representation for hand movement after peripheral motor denervation. (Paper)
39. CIR Morphology, Turbulence, Discontinuities, and Energetic Particles
40. Origin, Injection, and Acceleration of CIR Particles: Theory Report of Working Group 7
41. Corotating Interaction Regions at High Latitudes
42. The climatic challenge: Which plants will people use in the next century?
43. Anomalous Cosmic Rays
44. Cosmic Rays as Messengers from Outside the Inner Heliosphere
45. Direct observations of interstellar H, He, and O by the interstellar boundary explorer
46. The Makibg of Harper's Ferry National Historical Park: A Devil, Two Rivers, and a Dream
47. Archaeology as a Tool of Civic Engagement
48. New Solutions for House Museums: Ensuring the Long-Term Preservation of America's Historic Houses
49. ''Let a Common Interest Bind Us Together'': Associations, Partisanship, and Culture in Philadelphia, 1775-1840
50. Defining Memory: Local Museums and the Construction of History in America's Changing Communities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.